Changing management of retinoblastoma

Clinical and Experimental Ophthalmology

Volumn 32, Issue 4, 2004, Pages 345-346

  Shields, Carol L ^a   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; VINCRISTINE;

CANCER CONTROL; CANCER SURVIVAL; CATARACT; CRYOTHERAPY; EDITORIAL; ENUCLEATION; HUMAN; HYPERTHERMIC THERAPY; LEUKOKORIA; MYDRIASIS; RETINOBLASTOMA; RETINOPATHY; SURVIVAL RATE; TREATMENT FAILURE; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CHILD, PRESCHOOL; CRYOTHERAPY; EYE ENUCLEATION; HUMANS; HYPERTHERMIA, INDUCED; INFANT; OPHTHALMOLOGY; RETINAL NEOPLASMS; RETINOBLASTOMA; SURVIVAL RATE;

EID: 4444361659     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2004.00834.x     Document Type: Editorial

References (13)

1. Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus 1999; 36: 8-18.
2. Shields JA, Shields CL, Management and prognosis of retinoblastoma. In: Intraocular Tumors. A Text and Atlas. Philadelphia: WB Saunders, 1992; 377-92.
3. Shields JA, Shields CL, Retinoblastoma. In: Atlas of Intraocular Tumors. Philadelphia: Lippincott, Williams & Wilkins, 1999; 207-31.
4. Shields CL, Meadows AT, Shields JA, Carvalho C, Smith A. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol 2001; 119: 1269-72.
5. Moll AC, Imhof SM, Schouten-Van Meeteren AY, Boers M, Van Leeuwen F, Hofman P. Chemoreduction for retinoblastoma. Arch Ophthalmol 2003; 121: 1513.
6. Dondey JC, Staffieri S, McKenzie J, Davie G, Elder J. Retinoblastoma in Victoria, 1976-2000: changing management trends and outcomes. Clin Experiment Ophthalmol 2004; 32: 354-9.
7. Shields CL, Gorry T, Shields JA. Outcome of eyes with unilateral sporadic retinoblastoma based oil initial external findings by the family and pediatrician. J Pediatr Ophthalmol Strabismus 2004; 41: 143-9.
8. Canzano JC, Handa JT. Utility of pupillary dilation for detecting leukocoria in patients with retinoblastoma. Pediatrics 1999; 104: c44.
9. Metz T, Nelson L, Shields CL. Pupillary dialtion by pediatricians. Pediatrics 1999; 104: 958-60.
10. Epstein J, Shields CL, Shields JA. Trends in the management of retinoblastoma: evaluation of 1196 consecutive eyes during 1974-2001. J Pediatr Ophthalmol Strabismus 2003; 40: 196-203.
11. Shields CL, Honavar SC, Shields JA, Demirci H, Meadows AT, Naduvilath TJ. Factors predictive of recurrence of retinal tumor, vitreous seeds and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 2002; 120: 460-64.
12. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000; 18: 12-17.
13. Shields CL, Honavar SG, Meadows AT et al. Chemoreduction plus focal therapy for retinoblastoma: Factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002; 133: 657-64.